MEDIFAST INC Net Worth
MEDIFAST INC Net Worth Breakdown | MED |
MEDIFAST INC Net Worth Analysis
MEDIFAST INC's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including MEDIFAST INC's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of MEDIFAST INC's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform MEDIFAST INC's net worth analysis. One common approach is to calculate MEDIFAST INC's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares MEDIFAST INC's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing MEDIFAST INC's net worth. This approach calculates the present value of MEDIFAST INC's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of MEDIFAST INC's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate MEDIFAST INC's net worth. This involves comparing MEDIFAST INC's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into MEDIFAST INC's net worth relative to its peers.
Enterprise Value |
|
To determine if MEDIFAST INC is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding MEDIFAST INC's net worth research are outlined below:
| MEDIFAST INC is unlikely to experience financial distress in the next 2 years | |
| Over 86.0% of the company shares are owned by institutional investors | |
| Latest headline from kalkinemedia.com: Medifast Earnings Forecast and Stock Performance Outlook |
MEDIFAST INC uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in MEDIFAST INC. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to MEDIFAST INC's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 20th of February 2024 Upcoming Quarterly Report | View | |
| 6th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know MEDIFAST INC's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as MEDIFAST INC is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MEDIFAST INC backward and forwards among themselves. MEDIFAST INC's institutional investor refers to the entity that pools money to purchase MEDIFAST INC's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Dimensional Fund Advisors, Inc. | 2024-09-30 | 232.9 K | Arrowstreet Capital Limited Partnership | 2024-09-30 | 231.7 K | Federated Hermes Inc | 2024-09-30 | 216.9 K | State Street Corp | 2024-09-30 | 216.6 K | Susquehanna International Group, Llp | 2024-09-30 | 213.5 K | D. E. Shaw & Co Lp | 2024-09-30 | 208.8 K | Two Sigma Investments Llc | 2024-09-30 | 208.2 K | Man Group Plc | 2024-09-30 | 205.9 K | Jacobs Levy Equity Management, Inc. | 2024-09-30 | 169.4 K | Renaissance Technologies Corp | 2024-09-30 | 1 M | Blackrock Inc | 2024-06-30 | 829.2 K |
Follow MEDIFAST INC's market capitalization trends
The company currently falls under 'Small-Cap' category with a total capitalization of 215.15 M.Market Cap |
|
Project MEDIFAST INC's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.32 | 0.34 | |
| Return On Capital Employed | 0.58 | 0.61 | |
| Return On Assets | 0.32 | 0.34 | |
| Return On Equity | 0.49 | 0.84 |
When accessing MEDIFAST INC's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures MEDIFAST INC's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of MEDIFAST INC's profitability and make more informed investment decisions.
Please note, the presentation of MEDIFAST INC's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, MEDIFAST INC's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of MEDIFAST INC's management manipulating its earnings.
Evaluate MEDIFAST INC's management efficiency
MEDIFAST INC has Return on Asset of 0.0477 % which means that on every $100 spent on assets, it made $0.0477 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0366 %, implying that it generated $0.0366 on every 100 dollars invested. MEDIFAST INC's management efficiency ratios could be used to measure how well MEDIFAST INC manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.34. The current year's Return On Capital Employed is expected to grow to 0.61. At present, MEDIFAST INC's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 15.4 M, whereas Deferred Long Term Asset Charges is forecasted to decline to about 2.4 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 18.51 | 19.44 | |
| Tangible Book Value Per Share | 18.51 | 19.44 | |
| Enterprise Value Over EBITDA | 4.73 | 6.96 | |
| Price Book Value Ratio | 3.63 | 4.14 | |
| Enterprise Value Multiple | 4.73 | 6.96 | |
| Price Fair Value | 3.63 | 4.14 | |
| Enterprise Value | 397.2 M | 417.1 M |
MEDIFAST INC benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.
Enterprise Value Revenue 0.0931 | Revenue 674.5 M | Quarterly Revenue Growth (0.41) | Revenue Per Share 61.769 | Return On Equity 0.0366 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific MEDIFAST INC insiders, such as employees or executives, is commonly permitted as long as it does not rely on MEDIFAST INC's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases MEDIFAST INC insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
MEDIFAST INC Corporate Filings
| 13th of November 2024 Other Reports | ViewVerify | |
8K | 4th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 31st of October 2024 Other Reports | ViewVerify | |
F4 | 17th of September 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
MEDIFAST INC Earnings per Share Projection vs Actual
MEDIFAST INC Corporate Directors
| Ming Xian | Independent Director | Profile | |
| Michael Hoer | Independent Director | Profile | |
| Jeffrey Brown | Lead Independent Director | Profile | |
| Scott Schlackman | Independent Director | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MEDIFAST INC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. For information on how to trade MEDIFAST Stock refer to our How to Trade MEDIFAST Stock guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MEDIFAST INC. If investors know MEDIFAST will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MEDIFAST INC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.95) | Earnings Share 0.67 | Revenue Per Share 61.769 | Quarterly Revenue Growth (0.41) | Return On Assets 0.0477 |
The market value of MEDIFAST INC is measured differently than its book value, which is the value of MEDIFAST that is recorded on the company's balance sheet. Investors also form their own opinion of MEDIFAST INC's value that differs from its market value or its book value, called intrinsic value, which is MEDIFAST INC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MEDIFAST INC's market value can be influenced by many factors that don't directly affect MEDIFAST INC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MEDIFAST INC's value and its price as these two are different measures arrived at by different means. Investors typically determine if MEDIFAST INC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MEDIFAST INC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.